Aurora Cannabis Inc. (ACB)
| Previous Close | 1.5000 |
| Open | 1.5300 |
| Bid | 1.6400 x 29200 |
| Ask | 1.6500 x 29200 |
| Day's Range | 1.5100 - 1.7300 |
| 52 Week Range | 1.2100 - 8.6900 |
| Volume | |
| Avg. Volume | 11,169,570 |
| Market Cap | 497.698M |
| Beta (5Y Monthly) | 3.04 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.7020 |
| Earnings Date | Sept 26, 2022 - Sept 30, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.09 |
- Motley Fool
Why Tilray, Canopy, and Aurora Cannabis Just Jumped
After tumbling on Friday following a lousy earnings report from Canopy Growth (NASDAQ: CGC), shares of fellow Canadian marijuana stocks Tilray (NASDAQ: TLRY) and Aurora Cannabis (NASDAQ: ACB) -- and Canopy Growth, too -- are rebounding sharply today. As of 11:30 a.m. ET, Tilray shares are gaining 10.2%, Aurora is up 12.3%, and Canopy Growth is doing best of all, jumping 16.4%. The opposite is more accurate, with investment bank Piper Sandler coming out with a lower price target on Canopy -- $2.50 per share, down from $3 previously -- and an underweight rating to boot.
- Yahoo Finance Video
Cannabis: Inconsistent U.S. regulation is ‘Prohibition 2.0’, Green Thumb CEO says
Green Thumb Industries Founder and CEO Ben Kovler breaks down the cannabis company's second-quarter earnings beat while diving into the outlook of marijuana legalization and marijuana conviction turnovers in the U.S.
- Yahoo Finance Video
Cannabis: ‘The U.S. is a $100 billion opportunity,’ Tilray CEO says
Tilray CEO Irwin Simon joins Yahoo Finance Live to discuss earnings, cannabis legalization, and the outlook for the market for marijuana.
